Che-1/AATF诱导的转录活跃染色质促进多发性骨髓瘤细胞增殖
该研究探讨Che-1/AATF(Che-1)在多发性骨髓瘤(MM)中的作用,发现Che-1通过影响染色质结构维持全局基因表达促进MM增殖,其缺失导致组蛋白乙酰化降低和活跃染色质减少;在浆细胞中表达人Che-1的转基因小鼠发生类似人类MM的疾病;Che-1下调减少BRD4染色质积累并增敏溴结构域和外部结构域抑制剂。
要点
- Che-1缺失降低组蛋白乙酰化,减少活跃染色质。
- Che-1与组蛋白直接互作并置换I类组蛋白去乙酰化酶。
- Che-1下调减少BRD4染色质积累,增敏BET抑制剂。
核心结论
- Che-1通过影响染色质结构维持全局基因表达促进MM增殖,是MM治疗的潜在靶点,可单独或联合溴结构域和外部结构域抑制剂使用。
研究设计与样本
- 研究采用细胞与分子实验及转基因小鼠模型,未报告具体样本量。
主要发现
- Che-1缺失导致组蛋白乙酰化全局降低,活跃染色质减少。
- Che-1直接与组蛋白互作并置换I类组蛋白去乙酰化酶成员。
- 在浆细胞中表达人Che-1的转基因小鼠发生MM,临床特征类似人类疾病。
- Che-1下调减少BRD4染色质积累,增敏MM细胞对溴结构域和外部结构域抑制剂的反应。
临床怎么用
- Che-1可能作为MM治疗靶点,联合溴结构域和外部结构域抑制剂具有增敏潜力。
局限性
- 摘要未报告研究的具体局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Multiple myeloma (MM) is a hematologic malignancy produced by a clonal expansion of plasma cells and characterized by abnormal production and secretion of monoclonal antibodies. This pathology exhibits an enormous heterogeneity resulting not only from genetic alterations but also from several epigenetic dysregulations. Here we provide evidence that Che-1/AATF (Che-1), an interactor of RNA polymerase II, promotes MM proliferation by affecting chromatin structure and sustaining global gene expression. We found that Che-1 depletion leads to a reduction of "active chromatin" by inducing a global decrease of histone acetylation. In this context, Che-1 directly interacts with histones and displaces histone deacetylase class I members from them. Strikingly, transgenic mice expressing human Che-1 in plasma cells develop MM with clinical features resembling those observed in the human disease. Finally, Che-1 downregulation decreases BRD4 chromatin accumulation to further sensitize MM cells to bromodomain and external domain inhibitors. These findings identify Che-1 as a promising target for MM therapy, alone or in combination with bromodomain and external domain inhibitors.
引用
- Bruno T, De Nicola F, Corleone G, et al. Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myeloma. Blood Adv. 2020. PMID: 33186461. doi:10.1182/bloodadvances.2020002566
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。